Global Point-of-care Testing (POCT) for Pregnancy Market Growth 2023-2029

Global Point-of-care Testing (POCT) for Pregnancy Market Growth 2023-2029

Product Code:528031

Published Date: Feb 24,2023

Pages: 105

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Point-of-care Testing (POCT) for Pregnancy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Point-of-care Testing (POCT) for Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Point-of-care Testing (POCT) for Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Point-of-care Testing (POCT) for Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Point-of-care Testing (POCT) for Pregnancy players cover Abbott, BioMerieux, Guangzhou Wondfo Biotech Co.,Ltd., Beijing Hotgen Biotech Co.,ltd., Assure Tech (Hangzhou) Co.,Ltd., Siemens Healthineers, Roche, Danaher and Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Point-of-care Testing (POCT) for Pregnancy Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Pregnancy sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Pregnancy sales for 2023 through 2029. With Point-of-care Testing (POCT) for Pregnancy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Pregnancy industry.

This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Pregnancy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Pregnancy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-care Testing (POCT) for Pregnancy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Pregnancy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Pregnancy.

This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Pregnancy market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Based on Chemiluminescence Technology
    Based on Biosensor
    Based on Colloidal Gold
    Others

Segmentation by application
    Hospital
    lndependent Testing Organization

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Abbott
    BioMerieux
    Guangzhou Wondfo Biotech Co.,Ltd.
    Beijing Hotgen Biotech Co.,ltd.
    Assure Tech (Hangzhou) Co.,Ltd.
    Siemens Healthineers
    Roche
    Danaher
    Bio-Rad Laboratories
    LifeScan
    J.H.Bio-Tec

Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-of-care Testing (POCT) for Pregnancy market?
What factors are driving Point-of-care Testing (POCT) for Pregnancy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-care Testing (POCT) for Pregnancy market opportunities vary by end market size?
How does Point-of-care Testing (POCT) for Pregnancy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?